Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • World View
  • Published:

Stigma: a major barrier to hepatitis B elimination

Subjects

Advances in hepatitis B management are still not reaching most of the affected community. A major barrier to this translation is stigma. Research and clinical communities have a responsibility to mitigate stigma and ensure that the voices of the affected community are considered in decision-making conversations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Acknowledgements

T.T. is funded by the Australian Centre for HIV and Hepatitis Virology Research and the Australian National Health and Medical Research Council (Ideas Grant APP2002565). T.T. thanks S. Wang and J. Block for their bravery in publicizing their status to overcome the author’s own self-stigma; T.T. also acknowledges S. Wang for helpful conversations on this topic.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Tu.

Ethics declarations

Competing interests

T.T. consults for and advises for Gilead, Excision Biosciences and GlaxoSmithKline and has received research funding from Gilead and Excision Biosciences. T.T. is currently president of the Australian Centre for Hepatitis Virology and founder/director of HepBcommunity.org, an online support network for people living with hepatitis B.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tu, T. Stigma: a major barrier to hepatitis B elimination. Nat Rev Gastroenterol Hepatol 19, 622 (2022). https://doi.org/10.1038/s41575-022-00670-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41575-022-00670-2

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing